With mterest we read the report on the ESPS 2 tnal (Diener et al, 1996), in which dipyndamole appeaied effective when added to aspirin in the secondary pieven üon after ceiebral ischemia These results are remarkable, since they are at vanance to a laige body of evidence that points to no effect of the combmation dipyndamole and aspiim m companson to aspirin only, regardless of the mdication (Antiplatelet Tuahsts ' Collaboiation, 1994, Can negieter et al, 1994 From the report we undei stand that a number of patients were excluded fiom the analysis because of major protocol deviations This conceined the considerable number of 452 patients, amounting up to 6 4% of the total number of patients randomized Since, although possibly defendable, this constitutes a depaiture fiom the mtention-to-treat pnnciple, we think it important to know if outcome event data aie available on these patients, and if the results on this large group that was deleted from the published analysis were different fiom the published results, i e , was a sirmlai effect of dipyndamole plus aspnin found an exaggerated effect, or no effect 
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